Nanox Announces Collaboration With AhealthZ and SCL Science to Enter South Korean Market
Nanox Announces Collaboration With AhealthZ and SCL Science to Enter South Korean Market
AhealthZ to aid Nanox's pursuit of local authorizations and licenses for Nanox.ARC in South Korea
AHealthz 將幫助 Nanox 在韓國獲得 Nanox.arc 的當地授權和許可
SCL Science to integrate Nanox's artificial intelligence solutions in operations
SCL Science 將 Nanox 的人工智能解決方案整合到運營中
PETAH TIKVA, Israel, April 09, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced a new collaboration to advance the Nanox.ARC 3D imaging system and Nanox artificial intelligence (AI) solutions in Korea with AhealthZ – a distributor of healthcare services and devices – and SCL Science, AhealthZ's affiliated company and subsidiary of global healthcare group SCL (Seoul Clinical Laboratories).
以色列佩塔提克瓦，2024年4月9日（環球新聞專線）——創新的醫學成像技術公司NANO-X IMAGING LTD（納斯達克股票代碼：NNOX）（“Nanox” 或 “公司”）今天宣佈與醫療保健服務和設備分銷商AHealthz和澳大利亞SCL Science進行新的合作，在韓國推進Nanox.arc 3D成像系統和Nanox人工智能（AI）解決方案 Healthz 的附屬公司和全球醫療保健集團SCL（首爾臨床實驗室）的子公司。
Under the collaboration, AhealthZ plans to assist Nanox in efforts to secure local authorizations and licenses to enable the importation, marketing and sales of the Nanox.ARC in South Korea. The Nanox.ARC is a digital tomosynthesis system that uses multiple sources of X-rays to produce a three-dimensional, tomographic images. Compared to similar X-ray tomosynthesis based devices, Nanox.ARC has a smaller footprint, utilizes a cold cathode system, and has the potential to be a cost-effective and scalable imaging solution in healthcare settings.
根據該合作，AHealthz計劃協助Nanox努力獲得當地的授權和許可，以實現Nanox.arc在韓國的進口、營銷和銷售。Nanox.arc 是一種數字斷層合成系統，它使用多個 X 射線源生成三維斷層影像。與類似的基於X射線斷層合成的設備相比，Nanox.arc佔地面積更小，採用冷陰極系統，有可能成爲醫療保健環境中具有成本效益和可擴展的成像解決方案。
The collaboration will also include SCL Science integrating Nanox's AI solutions in remote image analysis and other operations. Nanox's AI solutions include its HealthCCSng cardiac solution, HealthOST bone solution and HealthFLD fatty liver solution, and are designed to help identify patients with asymptomatic undetected chronic disease and initiate earlier diagnosis and preventative management. Additionally, Nanox.MARKETPLACE, a teleradiology services platform that provides remote access to radiology and cardiology experts, will potentially be integrated with SCL Science's teleradiology centers in South Korea and other overseas markets.
合作還將包括SCL Science將Nanox的人工智能解決方案集成到遠程圖像分析和其他操作中。Nanox的人工智能解決方案包括其HealthCCSNG心臟解決方案、HealthHost骨解決方案和HealthFLD脂肪肝解決方案，旨在幫助識別未被發現的無症狀慢性病患者並啓動早期診斷和預防性管理。此外，Nanox.Marketplace是一個遠程放射學服務平台，可遠程訪問放射學和心臟病學專家，有可能與SCL Science在韓國和其他海外市場的遠程放射學中心整合。
"We are excited to work with AhealthZ and SCL Science to bring our comprehensive medical imaging solutions to South Korea, a country of over 51 million people and one of the world's most advanced technological markets," said Erez Meltzer, Nanox Chief Executive Officer. "This collaboration is a mutually beneficial opportunity that provides a pathway for Nanox to establish a presence for the Nanox.ARC and expand our AI solutions portfolio, as well as for SCL to leverage cutting-edge AI solutions in its efforts to advance digital health research and professional medical services."
Nanox首席執行官埃雷茲·梅爾策表示：“我們很高興能與aHealthz和SCL Science合作，將我們全面的醫學成像解決方案帶到韓國，這個擁有超過5100萬人口的國家，也是世界上最先進的技術市場之一。”“這種合作是一個互惠互利的機會，爲Nanox提供了在Nanox.arc建立業務並擴大我們的人工智能解決方案組合的途徑，也爲SCL利用尖端的人工智能解決方案來努力推進數字健康研究和專業醫療服務提供了途徑。”
譯文內容由第三人軟體翻譯。